Robert Altwasser

Learn More
Fungal infections have increased dramatically in the last 2 decades, and fighting infectious diseases requires innovative approaches such as the combination of two drugs acting on different targets or even targeting a salvage pathway of one of the drugs. The fungal cell wall biosynthesis is inhibited by the clinically used antifungal drug caspofungin. This(More)
Discovery of essential genes in pathogenic organisms is an important step in the development of new medication. Despite a growing number of genome data available, little is known about C. albicans, a major fungal pathogen. Most of the human population carries C. albicans as commensal, but it can cause systemic infection that may lead to the death of the(More)
Mitogen activated protein kinases (MAPKs) are highly conserved in eukaryotic organisms. In pathogenic fungi, their activities were assigned to different physiological functions including drug adaptation and resistance. Aspergillus fumigatus is a human pathogenic fungus, which causes life-threatening invasive infections. Therapeutic options against invasive(More)
Reverse engineering of full-genomic interaction networks based on compendia of expression data has been successfully applied for a number of model organisms. This study adapts these approaches for an important non-model organism: The major human fungal pathogen Candida albicans. During the infection process, the pathogen can adapt to a wide range of(More)
We investigate the almost surely asymptotic stability of gene regulatory networks (GRNs) with Markovian switching. Previous research has described GRNs as coupled nonlinear stochastic systems under parametric perturbations without considering the important aspect of different time-delays in the subsystems. However, a realistic model of a GRN is that of a(More)
  • 1